thiazolidines has been researched along with Focal Segmental Glomerulosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Betsholtz, C; Dunér, F; Hultenby, K; Patrakka, J; Sistani, L; Tryggvason, K; Udumala, S; Uhlen, M; Wernerson, A | 1 |
| Fujii, W; Ishikawa, S; Kawata, T; Koike, T; Makita, Z; Nakamura, S; Yanagisawa, K; Yasumura, K | 1 |
2 other study(ies) available for thiazolidines and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Pdlim2 is a novel actin-regulating protein of podocyte foot processes.
Topics: Actin Cytoskeleton; Actinin; Adaptor Proteins, Signal Transducing; Angiopoietin-Like Protein 1; Animals; Blotting, Western; Bridged Bicyclo Compounds, Heterocyclic; Cell Adhesion; Extracellular Matrix; Fluorescent Antibody Technique; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; HEK293 Cells; Humans; Immunoprecipitation; LIM Domain Proteins; Membrane Proteins; Mice; Microscopy, Immunoelectron; Nephrosis, Lipoid; Podocytes; Proteinuria; Reverse Transcriptase Polymerase Chain Reaction; Stress Fibers; Thiazolidines; Transcription Factors; Transfection; Two-Hybrid System Techniques | 2011 |
Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation.
Topics: Animals; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Glomerulosclerosis, Focal Segmental; Glycation End Products, Advanced; Male; Rats; Rats, Inbred Strains; Thiadiazoles; Thiazolidines | 1997 |